tiprankstipranks
Trending News
More News >
Sinovac Biotech (SVA)
NASDAQ:SVA
US Market

Sinovac Biotech (SVA) Revenue

Compare
116 Followers

Sinovac Biotech Revenue

Sinovac Biotech had a revenue of 307.87M in the quarter ending Dec 31, 2023, with 119.27%. This bring the company's revenue in the last twelve months to 448.27M, Decreased 6.51%. In the fiscal year ending Dec 31, 2023, Sinovac Biotech had annual revenue of 448.27M with -69.97% growth.
Revenue (ttm)
448.27M
Revenue Growth
1.98%
P/S Ratio
1.03
Revenue/Employee
$228,825
Employees
1,959
Market Cap
$460.27M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2023448.27M-1.04B-69.97%
Dec 31, 20221.49B-17.88B-92.30%
Dec 31, 202119.37B18.86B+3,694.36%
Dec 31, 2020510.62M264.57M+107.53%
Dec 31, 2019246.05M16.40M+7.14%
Dec 31, 2018229.65M55.30M+31.72%
Dec 31, 2017174.35M101.92M+140.71%
Dec 31, 201672.43M5.02M+7.44%
Dec 31, 201567.41M4.48M+7.12%
Dec 31, 201462.93M-8.84M-12.32%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis